Sign In
Buy SNY
$43.98
-0.680 (-1.52%)
At Close: Jul 20, 2026
AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session
EU regulator backs Sanofi's injectable version of blood cancer drug
09:36am, Friday, 27'th Mar 2026
French drugmaker Sanofi said on Friday the European Medicines Agency has recommended the approval of a subcutaneous version of its blood cancer drug administered through an on-body injector.
Press release: Availability of the Q1 2026 aide-mémoire
02:30am, Tuesday, 24'th Mar 2026
Availability of the Q1 2026 aide-mémoire Paris, France – March 24, 2026. Sanofi announced today the availability of its Q1 2026 aide-mémoire on the "Investors" page of the company's website: First
Sanofi and Regeneron's Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment
07:57am, Monday, 23'rd Mar 2026
Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi to develop the privately held firm's experimental treatment for several autoimmune disease
Sanofi launches innovation and operation centre in China
10:58am, Friday, 20'th Mar 2026
French drugmaker Sanofi launched an innovation and operation centre in the southwestern Chinese city of Chengdu on Thursday, the company said in a statement released on its Chi
TrumpRx lists many medicines at prices higher than paid in UK
02:23pm, Wednesday, 18'th Mar 2026
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
20 Years on Wall Street Taught Me: Big Dividend Healthcare Stocks Never Go Out of Style
07:19am, Wednesday, 18'th Mar 2026
After a career spanning two decades at Bear Stearns, Lehman Brothers, and Morgan Stanley, I gained an institutional perspective on dividend stock investing.
Mirecule Expands Strategic FSHD Collaboration with Sanofi
07:00am, Wednesday, 18'th Mar 2026
GAITHERSBURG, Md.--(BUSINESS WIRE)--Mirecule expands strategic collaboration with Sanofi on advancement of best-in-class ARC treatment of Facioscapulohumeral Muscular Dystrophy (FSHD).
Press Release: Sanofi's venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
02:00am, Wednesday, 18'th Mar 2026
Sanofi's venglusta t earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026 . The US Food and Drug Administration (FDA) has granted Breakthrough Therap
Big drugmakers must face US overcharge claims on medications for low-income patients
02:32pm, Tuesday, 17'th Mar 2026
A U.S. appeals court on Tuesday revived a whistleblower lawsuit accusing four large drugmakers of defrauding the federal and state governments out of hundreds of millions of dollars by overcharg
The Big 3: PR, ELF, SNY
01:27pm, Tuesday, 17'th Mar 2026
From oil, beauty, and therapeutic resource stocks, @ElliottWaveTrader's Tammy Marshall turns to three companies she sees as unsung market opportunities. The Fibonacci Princess offers insight and
Sanofi: An Undervalued Stock For Long-Term Dividend Growth Investors
11:03am, Monday, 16'th Mar 2026
Sanofi has increased its dividend for 31 consecutive years. That's a fantastic track record. Sanofi increased its revenue from €34.7 billion in FY 2016 to €43.6 billion in FY 2025. That's a compo
Callodine Capital Management LP Purchases 182,837 Shares of Sanofi $SNY
03:48am, Saturday, 14'th Mar 2026
Callodine Capital Management LP grew its stake in Sanofi (NASDAQ: SNY) by 35.5% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The
Sanofi: Information concerning the total number of voting rights and shares - February 2026
01:30pm, Thursday, 12'th Mar 2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement
